BJA FY25 Residential Substance Abuse Treatment for State Prisoners – Formula Grants Program | Apply Online

FAQs: BJA FY25 Residential Substance Abuse Treatment for State Prisoners Formula Grants Program

What is the BJA FY25 Residential Substance Abuse Treatment for State Prisoners Formula Grants Program?

It is a Bureau of Justice Assistance (BJA) funding opportunity that helps states strengthen residential substance use disorder (SUD) treatment in correctional settings and improve continuity of care as people transition from incarceration back into the community.

What is the main goal of this program?

The central goal is to expand access to evidence-based SUD treatment while an individual is in custody and maintain continuity of care through reentry, with the broader intent of supporting recovery, reducing relapse, and lowering recidivism.

Who is this program intended to serve?

The program focuses on both adult and juvenile populations who are detained or incarcerated and who need residential SUD treatment and related recovery supports.

What types of settings can be supported with this funding?

The funding supports residential SUD treatment in prisons and jails, including efforts that establish and maintain drug-free correctional environments.

Does the program emphasize residential treatment over other approaches?

Yes. A key emphasis is on structured, specialized residential programming rather than minimal or purely educational interventions.

Is evidence-based treatment required or encouraged?

The opportunity is intended to expand access to evidence-based treatment. In practice, funded programming is expected to reflect evidence-based approaches while people are in custody and as they reenter the community.

What does the NOFO say about co-occurring disorders?

The NOFO highlights the importance of addressing co-occurring disorders, encouraging programming capable of serving individuals who have both a substance use disorder and a mental health condition.

What does an integrated approach for co-occurring disorders typically imply?

It typically implies coordinated behavioral health screening, treatment planning, and clinically appropriate services that address substance use and mental health needs together rather than separately.

Is reentry and aftercare part of the program purpose?

Yes. Another major purpose is reentry preparation and recovery-oriented aftercare, with the idea that treatment should not stop at the facility gate.

What kinds of reentry supports are promoted under this program?

The program promotes planning and services that help individuals stabilize upon return to the community, including connections to community-based treatment providers and other recovery supports. Examples referenced include pre-release planning, referrals and warm handoffs to treatment, recovery support services, and broader aftercare to help address common reentry barriers.

Why is continuity of care emphasized?

The underlying idea is that outcomes improve when people can start or continue evidence-based care in custody and then move into community services without a gap in treatment.

Who is eligible to apply as the direct applicant?

Eligibility is limited to state governments. Only states can apply as the direct applicant for this opportunity.

Can local governments, tribal governments, or nonprofits apply directly?

Based on the information provided, the application itself must come from the state level. The description notes enhancing capabilities of state, local, and tribal governments, but it does not indicate that local, tribal, or nonprofit entities are eligible to apply directly.

Can states use the award to support partnerships with local agencies or providers?

Yes. States may use their awards to support activities and partnerships involving local correctional agencies, treatment providers, and other stakeholders, consistent with program rules.

Which federal agency administers this opportunity?

The opportunity is administered by the U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), through the Bureau of Justice Assistance (BJA).

What broader priorities does this opportunity align with?

It aligns with DOJ and OJP priorities related to public safety, the opioid crisis, and protecting civil rights.

What is the funding instrument type?

The funding instrument type is a grant.

What is the CFDA number for this program?

The CFDA is 16.593.

What is the opportunity number?

The opportunity number is O-BJA-2025-172576.

When was the notice created?

The notice was created on March 26, 2026.

What is the application closing date?

The application closing date listed is April 20, 2026.

What is the maximum award amount (award ceiling)?

The award ceiling shown is $1,207,840, which indicates the maximum amount available per award under the listed terms.

How many awards will be made?

The number of expected awards is not specified in the information provided.

What outcomes is this program trying to achieve?

The intended outcomes described include improved health and stability for justice-involved individuals and safer communities through reduced substance-related harm and better reentry success, including reductions in relapse and recidivism.

In plain terms, what is this program designed to help states do?

It is designed to help states expand and professionalize residential SUD treatment in correctional settings, ensure programs can serve people with co-occurring mental health needs, and build stronger bridges to community treatment and recovery supports after release.

Does the program support drug-free correctional environments?

Yes. The funding supports residential SUD treatment efforts in prisons and jails, including efforts that establish and maintain drug-free correctional environments.

Is the program limited to prisons only?

No. The information provided states that it supports residential SUD treatment in prisons and jails.

What category is this opportunity listed under?

It is categorized under law, justice, and legal services.